M

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Clinical Research Associate - I&I or Oncology, In-house

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$95k - $125k

About the Job

Requirements

  • A bachelor's degree in life sciences, nursing, pharmacy, or a related field.
  • At least 4 years of clinical monitoring experience, including at least 1 year of on-site CRA experience.
  • Experience overseeing CROs and third-party monitoring vendors, including KPI and performance management.
  • Strong knowledge of ICH GCP, FDA regulations, and sponsor oversight requirements.
  • Hands-on experience with EDC, CTMS, and eTMF systems.
  • A valid driver's license and passport, with ability to travel 30–40%.
  • Oncology clinical trial experience, particularly in solid tumors or hematologic malignancies.
  • Phase 1/2 experience, including SAD/MAD, PK/PD, or dose-escalation studies.
  • Familiarity with RECIST 1.1 or other oncology endpoints.
  • Experience with KPI dashboards and risk-based monitoring.
  • Ability to work in a hybrid arrangement with 70% office presence in the Boston office.
  • Availability for approximately 30–40% travel for site visits, co-monitoring, investigator meetings, and select international activities.

Responsibilities

  • Oversee CRO and vendor monitoring performance, including KPIs, monitoring quality, timelines, site risk, deviations, and CAPAs.
  • Review monitoring visit reports and ensure findings and follow-up actions are appropriately documented and resolved.
  • Conduct co-monitoring, for-cause, qualification, initiation, routine monitoring, and close-out visits as required.
  • Perform SDV, SDR, remote monitoring, data review, query management, and data cleaning.
  • Monitor site compliance with protocols, ICH GCP, FDA regulations, and applicable local requirements.
  • Track and resolve site issues, protocol deviations, and CAPAs.
  • Maintain and quality-check the TMF and essential regulatory documents; support IRB/IEC submissions and renewals.
  • Coordinate study startup activities, including feasibility, site selection, contracts, budgets, regulatory approvals, and site activation.
  • Support investigator/site training, investigator meetings, data cuts, and study close-out activities.
  • Maintain CTMS, EDC, eTMF, KPI, KRI, and risk-based monitoring tools.
  • Collaborate with Clinical Operations, Regulatory, Data Management, Biostatistics, Pharmacovigilance, CROs, and clinical sites.
  • Contribute to CSRs, regulatory submissions, study reports, dashboards, and vendor performance assessments.

Desired Qualifications

  • Medidata Rave experience is strongly preferred.
  • SoCRA/CCRA or ACRP certification.

About the Company

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Monte Rosa Therapeutics develops molecular glue degraders (MGDs) to treat cancer and autoimmune/inflammatory diseases using its QuEEN discovery engine, a platform that fuses AI-guided chemistry, proteomics, and structural biology to design MGDs. MGDs work by bringing a target protein together with an E3 ligase, tagging the protein for destruction by the cell's proteasome rather than just inhibiting it. The company distinguishes itself with the QuEEN platform, partnerships with Roche and Novartis for joint development and funding, and a portfolio that includes MRT-2359, MRT-6160, and MRT-8102 as clinical-stage programs. Its goal is to discover, develop, and commercialize MGDs, grow its pipeline, and create value through collaborations, upfront payments, milestones, and royalties while delivering treatments for patients with serious diseases.

Company size
201-500
Company stage
IPO
Headquarters
Boston, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Monte Rosa Therapeutics

See more jobs